Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Total 13F shares
-
27,996,450
-
Share change
-
+1,827,945
-
Total reported value
-
$621,773,974
-
Put/Call ratio
-
37%
-
Price per share
-
$22.21
-
Number of holders
-
95
-
Value change
-
+$47,620,034
-
Number of buys
-
54
-
Number of sells
-
50
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q4 2022
As of 31 Dec 2022,
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,996,450 shares.
The largest 10 holders included
BVF INC/IL, VIKING GLOBAL INVESTORS LP, Deep Track Capital, LP, BlackRock Inc., JANUS HENDERSON GROUP PLC, MORGAN STANLEY, VANGUARD GROUP INC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.